Alliance Pharma Statistics

Total Valuation

Alliance Pharma has a market cap or net worth of GBP 239.47 million. The enterprise value is 325.99 million.

Market Cap	239.47M
Enterprise Value	325.99M

Important Dates

The next estimated earnings date is Friday, December 27, 2024.

Earnings Date	Dec 27, 2024
Ex-Dividend Date	n/a

Share Statistics

Alliance Pharma has 540.57 million shares outstanding. The number of shares has increased by 0.07% in one year.

Current Share Class	n/a
Shares Outstanding	540.57M
Shares Change (YoY)	+0.07%
Shares Change (QoQ)	+0.73%
Owned by Insiders (%)	0.05%
Owned by Institutions (%)	95.85%
Float	455.67M

Valuation Ratios

PE Ratio	n/a
Forward PE	9.49
PS Ratio	1.31
PB Ratio	1.07
P/TBV Ratio	n/a
P/FCF Ratio	8.25
P/OCF Ratio	n/a
PEG Ratio	1.68

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 6.24, with an EV/FCF ratio of 11.23.

EV / Earnings	-9.71
EV / Sales	1.78
EV / EBITDA	6.24
EV / EBIT	7.47
EV / FCF	11.23

Financial Position

The company has a current ratio of 2.93, with a Debt / Equity ratio of 0.47.

Current Ratio	2.93
Quick Ratio	1.97
Debt / Equity	0.47
Debt / EBITDA	2.02
Debt / FCF	3.64
Interest Coverage	4.22

Financial Efficiency

Return on equity (ROE) is -13.44% and return on invested capital (ROIC) is 7.47%.

Return on Equity (ROE)	-13.44%
Return on Assets (ROA)	5.98%
Return on Capital (ROIC)	7.47%
Revenue Per Employee	631,541
Profits Per Employee	-115,800
Employee Count	292
Asset Turnover	0.40
Inventory Turnover	2.72

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +18.42% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+18.42%
50-Day Moving Average	44.54
200-Day Moving Average	39.17
Relative Strength Index (RSI)	47.60
Average Volume (20 Days)	1,166,437

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Alliance Pharma had revenue of GBP 183.15 million and -33.58 million in losses. Loss per share was -0.06.

Revenue	183.15M
Gross Profit	108.82M
Operating Income	43.64M
Pretax Income	-49.10M
Net Income	-33.58M
EBITDA	51.53M
EBIT	43.64M
Loss Per Share	-0.06

Full Income Statement

Balance Sheet

The company has 19.27 million in cash and 105.79 million in debt, giving a net cash position of -86.52 million or -0.16 per share.

Cash & Cash Equivalents	19.27M
Total Debt	105.79M
Net Cash	-86.52M
Net Cash Per Share	-0.16
Equity (Book Value)	222.90M
Book Value Per Share	0.41
Working Capital	61.48M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 30.26 million and capital expenditures -1.23 million, giving a free cash flow of 29.04 million.

Operating Cash Flow	30.26M
Capital Expenditures	-1.23M
Free Cash Flow	29.04M
FCF Per Share	0.05

Full Cash Flow Statement

Margins

Gross margin is 59.42%, with operating and profit margins of 23.83% and -18.34%.

Gross Margin	59.42%
Operating Margin	23.83%
Pretax Margin	-26.81%
Profit Margin	-18.34%
EBITDA Margin	28.13%
EBIT Margin	23.83%
FCF Margin	15.85%

Dividends & Yields

Alliance Pharma does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-0.07%
Shareholder Yield	-0.07%
Earnings Yield	n/a
FCF Yield	n/a

Dividend Details

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Alliance Pharma has an Altman Z-Score of 1.93. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	1.93
Piotroski F-Score	n/a